Catherine A. Sohn Insider Trading $RUBY Rubius Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Catherine A. Sohn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Catherine A. Sohn. Catherine A. Sohn is in LANDEC CORP \CA\ ($LNDC) and Director in LANDEC CORP \CA\ ($LNDC) and Director in Jazz Pharmaceuticals plc ($JAZZ) and Director in Neuralstem, Inc. ($CUR) and Director in Axcella Health Inc. ($AXLA) and Director in Rubius Therapeutics, Inc. ($RUBY).

Catherine A. Sohn in Rubius Therapeutics, Inc.

Trading Symbol: RUBY
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Catherine A. Sohn: Director
Holdings: 2,500 shares
Latest Transaction: May 13 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Catherine A. Sohn in Rubius Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AXLA, JAZZ, LNDC, SNCA, RUBY

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 13 2021RUBYRubius Therapeutic ...Sohn Catherine A.DirectorOption ExerciseA23.2525,000581,25025,000
May 26 2020RUBYRubius Therapeutic ...Sohn Catherine A.DirectorOption ExerciseA6.2225,000155,50025,000
May 28 2019RUBYRubius Therapeutic ...Sohn Catherine A.DirectorOption ExerciseA16.2725,000406,75025,000
Jul 23 2018RUBYRubius Therapeutic ...Sohn Catherine A.DirectorBuyP23.002,50057,5002,5000 to 2.5 K
Jul 18 2018RUBYRubius Therapeutic ...Sohn Catherine A.DirectorOption ExerciseA23.0025,000575,00025,000

Page:   1